Preclinical data highlight that PKM2 modulation inhibits several important mechanisms underlying atopic dermatitis ...

Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

Shunyalabs.ai has launched ZeroMed, a next-generation automatic speech recognition (ASR) system designed specifically for healthcare environments. The company calls it “a breakthrough domain-optimized ...

Epstein sees a clear direction of travel in private markets. “The trend line is toward standardized data and repeatable ...

Shares of Engene Holdings Inc. (NASDAQ:ENGN) were trading at $10.34, up $4.33, or 72%, on word of additional preliminary data from the pivotal cohort of its ongoing phase II Legend trial testing ...

Network participation on Solana has dropped sharply, with the seven-day average of daily active addresses falling to about ...

Five AI-focused stocks led by Microsoft, Nvidia, and Amazon earn strong analyst ratings with multi-year growth catalysts ...

Allo-Evasion™ 5.0-engineered iPSC beta islets are designed to overcome immune rejection and provide durable glucose control without chronic immunosuppressionCompelling preclinical data demonstrate ...

The shift is cultural as much as financial. “My parents’ generation didn’t like loans… If you couldn’t afford it, you didn’t ...

The research aim is to develop an intelligent agent for cybersecurity systems capable of detecting abnormal user behavior ...

ASML faces limited upside amid slowing growth, rising costs, and export risks. Valuation models suggest intrinsic value is ...

But, in the spirit of prediction, I think material like this will soon be more than a sideshow and already sketches an ...